tirzepatide patient assistance programs program eli lilly Financial Assistance Options Zepbound Patient Assistance Program: The – Eli Lilly's Zepbound Becomes First – Tirzepatide Injection At-Home

[PMID: 30585609] PubMed record related to this compound for laboratory literature review

Sales have grown slowly over the years, and cost increases are causing Performance Sports to incur losses

Market Size & Growth Forecasts The global GLP-1 analogues market is estimated at $66.48 billion in 2025, projected to skyrocket to $879.9 billion by 2034, representing an impressive CAGR of ~33.2% Another source estimates the broader GLP-1 market at $47.74 billion in 2024, with a more conservative CAGR of 10.9% from 20252034

GLP-1 agonists like semaglutide directly improve insulin sensitivity and reduce fasting insulin levels

It ensures the treatments safety and effectiveness

Some also historically received other vaccines, such as the Johnson & Johnson vaccine, which is no longer available in the U.S